Overcoming cancer together and dedicated to the needs of patients in Pasadena, Houston, Brenham and Pasadena. University Cancer Centers offers state-of-the-art oncology services and cancer treatment.
June 30, 2013 (Newswire) - UCC combines PET scans and other advanced diagnostic imaging capabilities with chemotherapy treatments, infusion, brachytherapy, and implants for prostate conditions. The center is also a pioneer in the use of intensity-modulated radiation therapy (IMRT). IMRT can be used to treat cancers of the breast, lung, neck, head, prostate, and colorectal region.
At the head ofUniversity Cancer Centers is Dr. Mark A. D'Andrea, a board-certified radiation oncologist with clinical interests in low-dose-rate and high-dose-rate brachytherapy. He is also experienced in stereotactic radiosurgery, which helps to keep surrounding noncancerous tissues while targeting spinal tumors and primary brain cancer. Our personalized facilities are designed to serve rural patients who want the best care.
Offices in Houston and Pasadena, Texas, UCC maintains full oncology treatment facilities with chemotherapy and intensity-modulated radiation therapy (IMRT) capacities. Dr. Mark A. D'Andrea and his team offers new real-time prostate implant solutions and combine chemotherapy with beam modifiers to optimize cancer treatment planning systems. University Cancer Center offers a host of advanced diagnostic options, such as PET scans, and has a full pharmacy to meet patients' infusion therapy requirements.
Dr. D'Andrea has received multiple patents for radiation therapy devices . He takes pride in offering the latest IMRT technologies, as well as a full complement of stereotactic radiosurgery options to cut the side effects and damage to unaffected tissue when treating cancer. Dr. D'Andrea and the university cancer centers physicians recognize that unexpected events can occur at any time and offer 24/7 in-office and emergency room care should the need arise.